Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill A Rebuck

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Critical Care Medicine|October 16, 2004
Prevention of stress ulceration: current trends in critical careRyan J Daley, Jill A Rebuck, Lynda S Welage, et al.
Critical Care Medicine|June 23, 2006
Survival of propofol infusion syndrome in a head-injured patientStephanie Mallow Corbett, Jesse Moore, Jill A Rebuck, et al.
The Annals of Pharmacotherapy|September 15, 2005
Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendationsBruce W Neale, Eleanor L Mesler, Michael Young, et al.
Current Surgery|October 12, 2004
Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?Stephanie Mallow, Jill A Rebuck, Turner Osler, et al.
The Annals of Pharmacotherapy|January 24, 2008
Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infectionTram B Cat, William Charash, James Hebert, et al.
The Journal of Trauma|February 14, 2007
Time lapse and comorbidities influence patient knowledge and pursuit of medical care after traumatic splenectomyStephanie Mallow Corbett, Jill A Rebuck, Frederick B Rogers, et al.
Neurological Research|December 26, 2002
Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoinWilliam M Coplin, Denise H Rhoney, Jill A Rebuck, et al.
Pharmacotherapy|November 16, 2002
The critical care pharmacist: an essential intensive care practitionerJohn Papadopoulos, Jill A Rebuck, Cheryl Lober, et al.
Pharmacotherapy|July 29, 2008
Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unitCatherine E Murphy, Alison M Stevens, Nicholas Ferrentino, et al.
Critical Care Medicine|August 3, 2004
Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicityKeith M Olsen, Maria I Rudis, Jill A Rebuck, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Critical Care Medicine|October 16, 2004
Prevention of stress ulceration: current trends in critical careRyan J Daley, Jill A Rebuck, Lynda S Welage, et al.
Critical Care Medicine|June 23, 2006
Survival of propofol infusion syndrome in a head-injured patientStephanie Mallow Corbett, Jesse Moore, Jill A Rebuck, et al.
The Annals of Pharmacotherapy|September 15, 2005
Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendationsBruce W Neale, Eleanor L Mesler, Michael Young, et al.
Current Surgery|October 12, 2004
Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?Stephanie Mallow, Jill A Rebuck, Turner Osler, et al.
The Annals of Pharmacotherapy|January 24, 2008
Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infectionTram B Cat, William Charash, James Hebert, et al.
The Journal of Trauma|February 14, 2007
Time lapse and comorbidities influence patient knowledge and pursuit of medical care after traumatic splenectomyStephanie Mallow Corbett, Jill A Rebuck, Frederick B Rogers, et al.
Neurological Research|December 26, 2002
Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoinWilliam M Coplin, Denise H Rhoney, Jill A Rebuck, et al.
Pharmacotherapy|November 16, 2002
The critical care pharmacist: an essential intensive care practitionerJohn Papadopoulos, Jill A Rebuck, Cheryl Lober, et al.
Pharmacotherapy|July 29, 2008
Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unitCatherine E Murphy, Alison M Stevens, Nicholas Ferrentino, et al.
Critical Care Medicine|August 3, 2004
Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicityKeith M Olsen, Maria I Rudis, Jill A Rebuck, et al.
Pageof 3